These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 26644312)

  • 1. Decreased Frequency and Secretion of CD26 Promotes Disease Progression in Indian Post Kala-azar Dermal Leishmaniasis.
    Mukherjee S; Mukhopadhyay D; Ghosh S; Barbhuiya JN; Das NK; Chatterjee M
    J Clin Immunol; 2016 Jan; 36(1):85-94. PubMed ID: 26644312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced lesional Foxp3 expression and peripheral anergic lymphocytes indicate a role for regulatory T cells in Indian post-kala-azar dermal leishmaniasis.
    Ganguly S; Mukhopadhyay D; Das NK; Chaduvula M; Sadhu S; Chatterjee U; Rahman M; Goswami RP; Guha SK; Modak D; Mallik S; Gonju D; Pramanik N; Barbhuiya JN; Saha B; Chatterjee M
    J Invest Dermatol; 2010 Apr; 130(4):1013-22. PubMed ID: 20032994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of cellular immunological responses in mono- and polymorphic clinical forms of post-kala-azar dermal leishmaniasis in India.
    Kaushal H; Bras-Gonçalves R; Avishek K; Kumar Deep D; Petitdidier E; Lemesre JL; Papierok G; Kumar S; Ramesh V; Salotra P
    Clin Exp Immunol; 2016 Jul; 185(1):50-60. PubMed ID: 26948150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-10- and TGF-beta-mediated susceptibility in kala-azar and post-kala-azar dermal leishmaniasis: the significance of amphotericin B in the control of Leishmania donovani infection in India.
    Saha S; Mondal S; Ravindran R; Bhowmick S; Modak D; Mallick S; Rahman M; Kar S; Goswami R; Guha SK; Pramanik N; Saha B; Ali N
    J Immunol; 2007 Oct; 179(8):5592-603. PubMed ID: 17911647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-situ immune profile of polymorphic vs. macular Indian Post Kala-azar dermal leishmaniasis.
    Sengupta R; Mukherjee S; Moulik S; Mitra S; Chaudhuri SJ; Das NK; Chatterjee U; Chatterjee M
    Int J Parasitol Drugs Drug Resist; 2019 Dec; 11():166-176. PubMed ID: 31542359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired activation of lesional CD8
    Mukherjee S; Sengupta R; Mukhopadhyay D; Braun C; Mitra S; Roy S; Kanti Das N; Chatterjee U; von Stebut E; Chatterjee M
    Sci Rep; 2019 Jan; 9(1):762. PubMed ID: 30679687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of serological markers to monitor the disease status of Indian post kala-azar dermal leishmaniasis.
    Mukhopadhyay D; Das NK; De Sarkar S; Manna A; Ganguly DN; Barbhuiya JN; Maitra AK; Hazra A; Chatterjee M
    Trans R Soc Trop Med Hyg; 2012 Nov; 106(11):668-76. PubMed ID: 22920931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-kala-azar dermal leishmaniasis--an overview.
    Ganguly S; Das NK; Barbhuiya JN; Chatterjee M
    Int J Dermatol; 2010 Aug; 49(8):921-31. PubMed ID: 21128917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of T cell-derived cytokines in post-kala-azar dermal leishmaniasis.
    Jafarzadeh A; Jafarzadeh S; Sharifi I; Aminizadeh N; Nozari P; Nemati M
    Cytokine; 2021 Nov; 147():155321. PubMed ID: 33039255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunopathology of post kala-azar dermal leishmaniasis (PKDL): T-cell phenotypes and cytokine profile.
    Ismail A; El Hassan AM; Kemp K; Gasim S; Kadaru AE; Moller T; Kharazmi A; Theander TG
    J Pathol; 1999 Dec; 189(4):615-22. PubMed ID: 10629566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired expression of CD26 compromises T-cell recruitment in human visceral leishmaniasis.
    Rai AK; Thakur CP; Kumar P; Mitra DK
    Eur J Immunol; 2012 Oct; 42(10):2782-91. PubMed ID: 22806538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for involvement of Th17 type responses in post kala azar dermal leishmaniasis (PKDL).
    Katara GK; Ansari NA; Singh A; Ramesh V; Salotra P
    PLoS Negl Trop Dis; 2012; 6(6):e1703. PubMed ID: 22724038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased levels of interleukin-10 and IgG3 are hallmarks of Indian post-kala-azar dermal leishmaniasis.
    Ganguly S; Das NK; Panja M; Pal S; Modak D; Rahaman M; Mallik S; Guha SK; Pramanik N; Goswami R; Barbhuiya JN; Saha B; Chatterjee M
    J Infect Dis; 2008 Jun; 197(12):1762-71. PubMed ID: 18444882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development of post-kala-azar dermal leishmaniasis (PKDL) is associated with acquisition of Leishmania reactivity by peripheral blood mononuclear cells (PBMC).
    Gasim S; Elhassan AM; Kharazmi A; Khalil EA; Ismail A; Theander TG
    Clin Exp Immunol; 2000 Mar; 119(3):523-9. PubMed ID: 10691926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dermatological Implications of Galectin-3 in Circulation: An Evaluation From the Perspective of Patients With Differential Manifestations of Post-Kala-Azar Dermal Leishmaniasis.
    Datta S; Ghosh M; Dewan K; Banerjee N; Saha B; Mukhopadhyay S
    Am J Dermatopathol; 2019 Dec; 41(12):897-907. PubMed ID: 30998516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Western blot analysis of humoral immune response to Leishmania donovani antigens in patients with post-kala-azar dermal leishmaniasis.
    Salotra P; Raina A; Ramesh V
    Trans R Soc Trop Med Hyg; 1999; 93(1):98-101. PubMed ID: 10492802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India.
    Singh RP; Picado A; Alam S; Hasker E; Singh SP; Ostyn B; Chappuis F; Sundar S; Boelaert M
    Trop Med Int Health; 2012 Nov; 17(11):1345-8. PubMed ID: 22882665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visceral Leishmaniasis IgG1 Rapid Monitoring of Cure vs. Relapse, and Potential for Diagnosis of Post Kala-Azar Dermal Leishmaniasis.
    Marlais T; Bhattacharyya T; Singh OP; Mertens P; Gilleman Q; Thunissen C; Hinckel BCB; Pearson C; Gardner BL; Airs S; de la Roche M; Hayes K; Hafezi H; Falconar AK; Eisa O; Saad A; Khanal B; Bhattarai NR; Rijal S; Boelaert M; El-Safi S; Sundar S; Miles MA
    Front Cell Infect Microbiol; 2018; 8():427. PubMed ID: 30619774
    [No Abstract]   [Full Text] [Related]  

  • 19. Cathelicidin augments VDR-dependent anti-leishmanial immune response in Indian Post-Kala-Azar Dermal Leishmaniasis.
    Das S; Sardar AH; Abhishek K; Kumar A; Rabidas VN; Das P
    Int Immunopharmacol; 2017 Sep; 50():130-138. PubMed ID: 28662432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leishmanin and tuberculin sensitivity in leishmaniasis in the Sudan, with special reference to kala-azar.
    Zijlstra EE; el-Hassan AM
    Trans R Soc Trop Med Hyg; 1993; 87(4):425-7. PubMed ID: 8249072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.